查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420935

液體切片市場[應用：腫瘤學、NIPT、移植診斷；循環生物標記：循環腫瘤細胞 (CTC)、遊離核酸、細胞外囊泡] - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Liquid Biopsy Market [Application: Oncology, NIPT, Transplant Diagnostics; Circulating Biomarker: Circulating Tumor Cells (CTC), Free Nucleic Acid, Extracellular Vesicles] - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 161 Pages | 商品交期: 2-10個工作天內

價格

液體活體組織切片市場 - 報告範圍

TMR 關於全球液體活體組織切片市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球液體活體組織切片市場的收入2017-2031年期間，考慮2023年為基準年，2031年為預測年。該報告還提供了2023年至2031年全球液體活體組織切片市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解液體活體組織切片市場。

市場概況
2023年市場價值 37 億美元
2031 年市場價值 77 億美元
CAGR 8.8%

該報告深入研究了全球液體活體組織切片市場的競爭格局。全球液體活體組織切片市場的主要參與者已經確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球液體活體組織切片市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設

第 3 章：研究方法

第 4 章：執行摘要

第 5 章：市場概覽

  • 介紹
  • 市場動態
  • 主要趨勢分析
  • 主要市場指標
  • 技術概況分析
  • 波特五力分析
  • 產業SWOT分析
  • 價值鏈分析
  • 規範架構
  • 全球市場分析與預測 - 2017-2031

第 6 章：全球市場分析與預測：按應用分類

  • 市場規模預測：依應用分類，2017-2031
    • 腫瘤學
    • NIPT
    • 移植診斷
    • 其他
  • 増量機會：按應用

第 7 章：全球市場分析與預測：透過循環生物標記

  • 市場規模預測：按循環生物標記，2017-2031
    • 循環腫瘤細胞 (CTC)
    • 遊離核酸
    • 細胞外囊泡/外泌體
  • 増量機會：by Circulated Biomarker

第 8 章：全球市場分析與預測：按最終用戶

  • 市場規模預測，最終用戶，2017-2031
    • 醫院
    • 參考實驗室
    • 學術及研究機構
    • 其他
  • 増量機會：by End-user

第 9 章：全球市場分析與預測：按地區

  • 市場規模預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲
  • 増量機會：依地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：中東和南非市場分析與預測

第 14 章：南美洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 -競爭儀表板
  • 市佔率分析（%）：依公司分類，（2022）
  • 公司簡介（詳細資訊 - 公司概述、銷售區域/地理位置、收入、策略和業務概述）
    • Biocept, Inc.
    • MDxHealth
    • Myriad Genetics, Inc.
    • Bio-Rad Laboratories
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Genomic Health, Inc.
    • Illumina, Inc.
    • 其他關鍵參與者

第16章：市場戦略

第 17 章：潛在市場空間的識別

第 18 章：普遍存在的市場風險

第 19 章：了解顧客的購買流程

第 20 章：首選銷售與行銷策略

Product Code: TMRGL22994

Liquid Biopsy Market - Scope of Report

TMR's report on the global liquid biopsy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global liquid biopsy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global liquid biopsy market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the liquid biopsy market.

Market Snapshot
Market Value in 2023US$ 3.7 Bn
Market Value in 2031US$ 7.7 Bn
CAGR8.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global liquid biopsy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global liquid biopsy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global liquid biopsy market.

The report delves into the competitive landscape of the global liquid biopsy market. Key players operating in the global liquid biopsy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global liquid biopsy market profiled in this report.

Key Questions Answered in Global liquid biopsy Market Report:

  • What is the sales/revenue generated by liquid biopsy across all regions during the forecast period?
  • What are the opportunities in the global liquid biopsy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Liquid Biopsy Market - Research Objectives and Research Approach

The comprehensive report on the global liquid biopsy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global liquid biopsy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global liquid biopsy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions

3. Research Methodology

4. Executive Summary

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
    • 5.2.2. Restraints
    • 5.2.3. Opportunities
  • 5.3. Key Trends Analysis
    • 5.3.1. Demand Side Analysis
    • 5.3.2. Supply Side Analysis
  • 5.4. Key Market Indicators
  • 5.5. Technological Overview Analysis
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Industry SWOT Analysis
  • 5.8. Value Chain Analysis
  • 5.9. Regulatory Framework
  • 5.10. Global Liquid Biopsy Market Analysis and Forecast, - 2017-2031
    • 5.10.1. Market Value Projections (US$ Mn)

6. Global Liquid Biopsy Market Analysis and Forecast, by Application

  • 6.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 6.1.1. Oncology
    • 6.1.2. NIPT
    • 6.1.3. Transplant Diagnostics
    • 6.1.4. Others
  • 6.2. Incremental Opportunity, by Application

7. Global Liquid Biopsy Market Analysis and Forecast, by Circulating Biomarker

  • 7.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 7.1.1. Circulating Tumor Cells (CTC)
    • 7.1.2. Free Nucleic Acid
    • 7.1.3. Exracellular Vesicles/Exosomes
  • 7.2. Incremental Opportunity, by Circulating Biomarker

8. Global Liquid Biopsy Market Analysis and Forecast, by End-user

  • 8.1. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
    • 8.1.1. Hospitals
    • 8.1.2. Reference Laboratories
    • 8.1.3. Academic and Research Institutes
    • 8.1.4. Others
  • 8.2. Incremental Opportunity, by End-user

9. Global Liquid Biopsy Market Analysis and Forecast, by Region

  • 9.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Region, 2017-2031
    • 9.1.1. North America
    • 9.1.2. Europe
    • 9.1.3. Asia Pacific
    • 9.1.4. Middle East & Africa
    • 9.1.5. South America
  • 9.2. Incremental Opportunity, by Region

10. North America Liquid Biopsy Market Analysis and Forecast

  • 10.1. Regional Snapshot
  • 10.2. Brand Analysis
  • 10.3. Price Trend Analysis
    • 10.3.1. Weighted Average Price
  • 10.4. Key Trends Analysis
    • 10.4.1. Demand Side
    • 10.4.2. Supplier Side
  • 10.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 10.5.1. Oncology
    • 10.5.2. NIPT
    • 10.5.3. Transplant Diagnostics
    • 10.5.4. Others
  • 10.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 10.6.1. Circulating Tumor Cells (CTC)
    • 10.6.2. Free Nucleic Acid
    • 10.6.3. Exracellular Vesicles/Exosomes
  • 10.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user - 2017-2031
    • 10.7.1. Hospitals
    • 10.7.2. Reference Laboratories
    • 10.7.3. Academic and Research Institutes
    • 10.7.4. Others
  • 10.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country - 2017-2031
    • 10.8.1. U.S.
    • 10.8.2. Canada
    • 10.8.3. Rest of North America
  • 10.9. Incremental Opportunity Analysis

11. Europe Liquid Biopsy Market Analysis and Forecast

  • 11.1. Regional Snapshot
  • 11.2. Brand Analysis
  • 11.3. Price Trend Analysis
    • 11.3.1. Weighted Average Price
  • 11.4. Key Trends Analysis
    • 11.4.1. Demand Side
    • 11.4.2. Supplier Side
  • 11.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 11.5.1. Oncology
    • 11.5.2. NIPT
    • 11.5.3. Transplant Diagnostics
    • 11.5.4. Others
  • 11.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 11.6.1. Circulating Tumor Cells (CTC)
    • 11.6.2. Free Nucleic Acid
    • 11.6.3. Exracellular Vesicles/Exosomes
  • 11.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
    • 11.7.1. Hospitals
    • 11.7.2. Reference Laboratories
    • 11.7.3. Academic and Research Institutes
    • 11.7.4. Others
  • 11.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
    • 11.8.1. U.K.
    • 11.8.2. Germany
    • 11.8.3. France
    • 11.8.4. Rest of Europe
  • 11.9. Incremental Opportunity Analysis

12. Asia Pacific Liquid Biopsy Market Analysis and Forecast

  • 12.1. Regional Snapshot
  • 12.2. Brand Analysis
  • 12.3. Price Trend Analysis
    • 12.3.1. Weighted Average Price
  • 12.4. Key Trends Analysis
    • 12.4.1. Demand Side
    • 12.4.2. Supplier Side
  • 12.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 12.5.1. Oncology
    • 12.5.2. NIPT
    • 12.5.3. Transplant Diagnostics
    • 12.5.4. Others
  • 12.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 12.6.1. Circulating Tumor Cells (CTC)
    • 12.6.2. Free Nucleic Acid
    • 12.6.3. Exracellular Vesicles/Exosomes
  • 12.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
    • 12.7.1. Hospitals
    • 12.7.2. Reference Laboratories
    • 12.7.3. Academic and Research Institutes
    • 12.7.4. Others
  • 12.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
    • 12.8.1. India
    • 12.8.2. China
    • 12.8.3. Japan
    • 12.8.4. Rest of Asia Pacific
  • 12.9. Incremental Opportunity Analysis

13. Middle East & South Africa Liquid Biopsy Market Analysis and Forecast

  • 13.1. Regional Snapshot
  • 13.2. Brand Analysis
  • 13.3. Price Trend Analysis
    • 13.3.1. Weighted Average Price
  • 13.4. Key Trends Analysis
    • 13.4.1. Demand Side
    • 13.4.2. Supplier Side
  • 13.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 13.5.1. Oncology
    • 13.5.2. NIPT
    • 13.5.3. Transplant Diagnostics
    • 13.5.4. Others
  • 13.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 13.6.1. Circulating Tumor Cells (CTC)
    • 13.6.2. Free Nucleic Acid
    • 13.6.3. Exracellular Vesicles/Exosomes
  • 13.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
    • 13.7.1. Hospitals
    • 13.7.2. Reference Laboratories
    • 13.7.3. Academic and Research Institutes
    • 13.7.4. Others
  • 13.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
    • 13.8.1. GCC
    • 13.8.2. Rest of Middle East & Africa
  • 13.9. Incremental Opportunity Analysis

14. South America Liquid Biopsy Market Analysis and Forecast

  • 14.1. Regional Snapshot
  • 14.2. Brand Analysis
  • 14.3. Price Trend Analysis
    • 14.3.1. Weighted Average Price
  • 14.4. Key Trends Analysis
    • 14.4.1. Demand Side
    • 14.4.2. Supplier Side
  • 14.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
    • 14.5.1. Oncology
    • 14.5.2. NIPT
    • 14.5.3. Transplant Diagnostics
    • 14.5.4. Others
  • 14.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
    • 14.6.1. Circulating Tumor Cells (CTC)
    • 14.6.2. Free Nucleic Acid
    • 14.6.3. Exracellular Vesicles/Exosomes
  • 14.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
    • 14.7.1. Hospitals
    • 14.7.2. Reference Laboratories
    • 14.7.3. Academic and Research Institutes
    • 14.7.4. Others
  • 14.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
    • 14.8.1. Brazil
    • 14.8.2. Rest of South America
  • 14.9. Incremental Opportunity Analysis

15. Competition Landscape

  • 15.1. Market Player - Competition Dashboard
  • 15.2. Market Share Analysis (%), by Company, (2022)
  • 15.3. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
    • 15.3.1. Biocept, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Sales Area
      • 15.3.1.3. Geographical Presence
      • 15.3.1.4. Revenue
      • 15.3.1.5. Strategy & Business Overview
    • 15.3.2. MDxHealth
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Sales Area
      • 15.3.2.3. Geographical Presence
      • 15.3.2.4. Revenue
      • 15.3.2.5. Strategy & Business Overview
    • 15.3.3. Myriad Genetics, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Sales Area
      • 15.3.3.3. Geographical Presence
      • 15.3.3.4. Revenue
      • 15.3.3.5. Strategy & Business Overview
    • 15.3.4. Bio-Rad Laboratories
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Sales Area
      • 15.3.4.3. Geographical Presence
      • 15.3.4.4. Revenue
      • 15.3.4.5. Strategy & Business Overview
    • 15.3.5. QIAGEN
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Sales Area
      • 15.3.5.3. Geographical Presence
      • 15.3.5.4. Revenue
      • 15.3.5.5. Strategy & Business Overview
    • 15.3.6. F. Hoffmann-La Roche Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Sales Area
      • 15.3.6.3. Geographical Presence
      • 15.3.6.4. Revenue
      • 15.3.6.5. Strategy & Business Overview
    • 15.3.7. Thermo Fisher Scientific, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Sales Area
      • 15.3.7.3. Geographical Presence
      • 15.3.7.4. Revenue
      • 15.3.7.5. Strategy & Business Overview
    • 15.3.8. Genomic Health, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Sales Area
      • 15.3.8.3. Geographical Presence
      • 15.3.8.4. Revenue
      • 15.3.8.5. Strategy & Business Overview
    • 15.3.9. Illumina, Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Sales Area
      • 15.3.9.3. Geographical Presence
      • 15.3.9.4. Revenue
      • 15.3.9.5. Strategy & Business Overview
    • 15.3.10. Other Key Players
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Sales Area
      • 15.3.10.3. Geographical Presence
      • 15.3.10.4. Revenue
      • 15.3.10.5. Strategy & Business Overview

16. Go to Market Strategy

17. Identification of Potential Market Spaces

18. Prevailing Market Risks

19. Understanding Buying Process of Customers

20. Preferred Sales & Marketing Strategy

List of Tables

  • Table 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 2: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 3: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 4: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Table 5: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 6: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 7: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 8: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Table 9: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 10: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 11: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 12: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Table 13: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 14: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 15: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 16: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Table 17: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 18: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 19: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 20: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Table 21: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Table 22: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Table 23: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Table 24: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031

List of Figures

  • Figure 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 2: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 3: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 4: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 5: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 6: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 7: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 8: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
  • Figure 9: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 10: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 11: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 12: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 13: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 14: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 15: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 16: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
  • Figure 17: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 18: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 19: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 20: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 21: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 22: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 23: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 24: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
  • Figure 25: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 26: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 27: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 28: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 29: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 30: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 31: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 32: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
  • Figure 33: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 34: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 35: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 36: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 37: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 38: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 39: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 40: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
  • Figure 41: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
  • Figure 42: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
  • Figure 43: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
  • Figure 44: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
  • Figure 45: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
  • Figure 46: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
  • Figure 47: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
  • Figure 48: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031